Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

The Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC), the first evidence‐based guidelines for the treatment of HCC in Japan, were compiled by an expert panel supported by the Japanese Ministry of Health, Labour, and Welfare. This set of guidelines covers six research fields: prevention, diagnosis and surveillance, surgery, chemotherapy, transarterial chemoembolization, and percutaneous local ablation therapy. A systematic review of the English medical literature on HCC was performed, and a total of 7192 publications were extracted, mainly from MEDLINE (1966–2002). After the second selection, 334 articles were adopted for the guidelines to form 58 pairs of research questions and recommendations. For the users' convenience, practical algorithms for the surveillance and treatment of HCC were also created, which were based on evidence from the selected articles forthe guidelines and modified according to the current status of medical practice in Japan, where liver resection for HCC is regarded as safe with less than 1% mortality and cadaveric donors for liver transplantation are extremely difficult to obtain. The formation of the guidelines and the outline of their contents are described. The Japanese HCC guidelines may be useful in decision making at every clinical step, both for patients and physicians. Although the main users of these guidelines are assumed to be Japanese physicians, the accumulated evidence and interpretation in the guidelines may attract universal attention.

[1]  V. Vilgrain,et al.  Preoperative chemoembolization of hepatocellular carcinoma: a comparative study. , 1998, Archives of surgery.

[2]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[3]  P Neuhaus,et al.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis , 2001, Hepatology.

[4]  F. Kurokawa,et al.  Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

[5]  S. Katagiri,et al.  Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. , 2001, Surgery.

[6]  S. Arii,et al.  Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy , 1992, Cancer.

[7]  H. Ueno,et al.  Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. , 2001, Japanese journal of clinical oncology.

[8]  E. Taioli,et al.  A Prospective Multicenter Study of Hepatocellular Carcinoma in Italian Hemophiliacs With Chronic Hepatitis C , 1998 .

[9]  Report of the 15th follow-up survey of primary liver cancer. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  Yasuo Ohashi,et al.  Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial , 2000, The Lancet.

[11]  S. Fan,et al.  Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Cottone,et al.  Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. , 1994, Journal of hepatology.

[13]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[14]  T. Starzl,et al.  Should hepatomas be treated with hepatic resection or transplantation? , 1999, Cancer.

[15]  A G Tzakis,et al.  Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. , 2001, Archives of surgery.

[16]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[17]  O. Ernst,et al.  Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. , 1999, AJR. American journal of roentgenology.

[18]  V. Vilgrain,et al.  Small Nodule Detection in Cirrhotic Livers: Evaluation with US, Spiral CT, and MRI and Correlation with Pathologic Examination of Explanted Liver , 2001, Journal of computer assisted tomography.

[19]  Aniruddha M. Deshpande,et al.  Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.

[20]  H. Hasegawa,et al.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.

[21]  M. Kaito,et al.  Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. , 2002, Hepato-gastroenterology.

[22]  K. Puntillo Acute pain management: operative or medical procedures and trauma. , 1993, Nursing dynamics.

[23]  F. Garbagnati,et al.  Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. , 1996, AJR. American journal of roentgenology.

[24]  M. Mayo-Smith,et al.  Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. , 1999, JAMA.

[25]  Y. Imai,et al.  Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches , 2002, Cancer.

[26]  N. Nagasue,et al.  Repeat hepatectomy for recurrent hepatocellular carcinoma , 1996, The British journal of surgery.

[27]  D. Yoshida,et al.  Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI , 2001, Abdominal Imaging.

[28]  S. Kawasaki,et al.  Prognostic significance of anatomical resection and des‐γ‐carboxy prothrombin in patients with hepatocellular carcinoma , 1999, The British journal of surgery.

[29]  S. Ryder Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults , 2003, Gut.

[30]  M. Ikeda,et al.  Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma. , 1997, Japanese journal of clinical oncology.

[31]  J. Wong,et al.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. , 2000, Annals of surgery.

[32]  R. Poon,et al.  Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. , 1999, Annals of surgery.

[33]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[34]  T. Livraghi,et al.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. , 1995, Radiology.

[35]  Steven A. Curley,et al.  Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis , 2000, Annals of surgery.

[36]  S. Kawasaki,et al.  Results of hepatic resection for hepatocellular carcinoma , 2004, World Journal of Surgery.

[37]  Lu-Yu Hwang,et al.  HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.

[38]  Michiie Sakamoto,et al.  Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection , 1996, Cancer.

[39]  S. Hadziyannis,et al.  Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus‐related cirrhosis: a meta‐analysis , 2001, Alimentary pharmacology & therapeutics.

[40]  O. Matsui,et al.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. , 1999, AJR. American journal of roentgenology.

[41]  H. Moriwaki,et al.  Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. , 1996, Digestion.

[42]  J. Wilson Liver Cancer on the Rise , 2005, Annals of Internal Medicine.

[43]  M. Makuuchi,et al.  Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. , 2006, World journal of gastroenterology.

[44]  H. Ueno,et al.  Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. , 2001, AJR. American journal of roentgenology.

[45]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[46]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[47]  A. Tamori,et al.  Effects of Long-Term Postoperative Interferon- Therapy on Intrahepatic Recurrence after Resection of Hepatitis C VirusRelated Hepatocellular Carcinoma , 2001, Annals of Internal Medicine.

[48]  D. Pateron,et al.  Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. , 1994, Journal of hepatology.

[49]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[50]  O. Matsui,et al.  Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. , 2002, Radiology.

[51]  M. Makuuchi,et al.  Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan , 2000, Hepatology.

[52]  O. Matsui,et al.  Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. , 1991, Radiology.

[53]  K. Koh,et al.  Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. , 2000, AJR. American journal of roentgenology.

[54]  E. Taioli,et al.  A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. , 1998, Blood.

[55]  S. Fan,et al.  Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective , 2002, Annals of surgery.

[56]  J W Marsh,et al.  Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. , 2000, Radiology.

[57]  M. Wu,et al.  [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma]. , 1999, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[58]  Y. Matsui,et al.  Preoperative determination of the surgical procedure for hepatectomy using technetium‐99m‐galactosyl human serum albumin (99mTc‐GSA) liver scintigraphy , 1997, Hepatology.

[59]  M. Makuuchi,et al.  Response of early-stage hepatocellular carcinoma and borderline lesions to therapeutic arterial embolization. , 1993, AJR. American journal of roentgenology.

[60]  K Arai,et al.  Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. , 1993, Radiology.

[61]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[62]  A. Tamori,et al.  Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. , 2001, Annals of internal medicine.

[63]  S Sawada,et al.  Transcatheter oily chemoembolization of hepatocellular carcinoma. , 1989, Radiology.

[64]  K. Man,et al.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy , 1997, The British journal of surgery.

[65]  M. Cottone,et al.  Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis , 2005, Digestive Diseases and Sciences.

[66]  T. Livraghi,et al.  Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. , 1997, Scandinavian journal of gastroenterology.

[67]  K. Sung,et al.  Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon‐α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis , 2000, Cancer.

[68]  N. Chalasani,et al.  Screening for hepatocellular carcinoma in patients with advanced cirrhosis , 1999, American Journal of Gastroenterology.

[69]  P. Andreone,et al.  Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. , 2001, Journal of hepatology.

[70]  T. Inoue,et al.  Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? , 1996, Annals of surgery.

[71]  J. Figueras,et al.  Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. , 2000, Journal of the American College of Surgeons.

[72]  M. Salvioni,et al.  Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. , 1998, Hepato-gastroenterology.

[73]  K. Chayama,et al.  The long term efficacy of glycyrrhizin in chronic hepatitis C patients , 1997, Cancer.

[74]  L. Pączek,et al.  [Liver transplantation for hepatocellular carcinoma]. , 2003, Polskie Archiwum Medycyny Wewnetrznej.

[75]  M. Makuuchi,et al.  Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus , 2001, Annals of surgery.

[76]  M. Sherman,et al.  Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis , 2001, Gut.

[77]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[78]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[79]  Pietro Andreone,et al.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. , 2002, Radiology.

[80]  H. Hasegawa,et al.  A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma , 1996, Japanese journal of cancer research : Gann.

[81]  M. Schwartz,et al.  Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[82]  G. Dodd,et al.  Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. , 1994, Radiology.

[83]  Guang-shun Yang,et al.  The effect of preoperative transcatheter hepatic arterial chemoembolization on disease‐free survival after hepatectomy for hepatocellular carcinoma , 1999, Cancer.